{"id":863507,"date":"2025-06-25T07:04:10","date_gmt":"2025-06-25T11:04:10","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/glaukos-to-celebrate-10th-anniversary-of-ipo-listing-with-nyse-closing-bell\/"},"modified":"2025-06-25T07:04:10","modified_gmt":"2025-06-25T11:04:10","slug":"glaukos-to-celebrate-10th-anniversary-of-ipo-listing-with-nyse-closing-bell","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/glaukos-to-celebrate-10th-anniversary-of-ipo-listing-with-nyse-closing-bell\/","title":{"rendered":"Glaukos to Celebrate 10th Anniversary of IPO Listing with NYSE Closing Bell"},"content":{"rendered":"<p>        <!--.bwalignc { text-align: center; list-style-position: inside }body {font:normal small Arial,Helvetica,sans-serif;color:#000;background-color:#fff;padding:24px;margin:0;} a img {border:0;} h3 {font-size:medium;color:#000;margin:0 0 1em 0; text-align:center;}-->  <\/p>\n<p class=\"bwalignc\"><b>Glaukos to Celebrate 10<sup>th<\/sup> Anniversary of IPO Listing with NYSE Closing Bell<\/b><\/p>\n<p>ALISO VIEJO, Calif.&#8211;(<a href=\"http:\/\/www.businesswire.com\">BUSINESS WIRE<\/a>)&#8211;<br \/>\nGlaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced it will celebrate the 10<sup>th<\/sup> anniversary of its Initial Public Offering (IPO) listing on the New York Stock Exchange (NYSE) by ringing The Closing Bell at 4:00 p.m. ET today, Wednesday, June 25, 2025.<\/p>\n<p>\n&#8220;Ringing the NYSE closing bell today is a proud and humbling moment for our company, commemorating ten years since our IPO and celebrating the tremendous progress we\u2019ve made in advancing our mission to transform vision therapies for the benefit of patients suffering from chronic eye diseases. This milestone would not have been possible without the unrelenting dedication of our teams, the trust of our customers and steadfast support of our partners and shareholders,\u201d said Thomas Burns, Glaukos chairman and chief executive officer. \u201cOver the past decade, Glaukos has grown from a single-product, U.S.-focused company into a diversified, global leader in ophthalmology, now with more than 1,000 employees around the world. Just as it did at the time of our IPO, innovation remains at the core of everything we do. I am deeply grateful for how far we\u2019ve come, and excited as we embark upon our next transformational decade ahead.&#8221;<\/p>\n<p>\nCoverage of the NYSE Closing Bell will be live streamed and on replay on the NYSE website at <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.nyse.com%2Fbell&amp;esheet=54281158&amp;newsitemid=20250625995676&amp;lan=en-US&amp;anchor=https%3A%2F%2Fwww.nyse.com%2Fbell&amp;index=1&amp;md5=b96b7087ef8d66d8856b3658ce6da575\">https:\/\/www.nyse.com\/bell<\/a>, and may also be viewed on various media outlets such as CNBC.<\/p>\n<p><b>About Glaukos<\/b><\/p>\n<p>\nGlaukos (<a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.glaukos.com&amp;esheet=54281158&amp;newsitemid=20250625995676&amp;lan=en-US&amp;anchor=www.glaukos.com&amp;index=2&amp;md5=98351b610a2df5419d0f5d47a5f95013\">www.glaukos.com<\/a>) is an ophthalmic pharmaceutical and medical technology company focused on developing and commercializing novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases. Glaukos first developed Micro-Invasive Glaucoma Surgery (MIGS) as an alternative to the traditional glaucoma treatment paradigm, launching its first MIGS device commercially in 2012. In 2024, Glaukos commenced commercial launch activities for <i>iDose<sup>\u00ae<\/sup> TR<\/i>, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical designed to deliver 24\/7 glaucoma drug therapy inside the eye for extended periods of time. Glaukos also markets the only FDA-approved corneal cross-linking therapy utilizing a proprietary bio-activated pharmaceutical for the treatment of keratoconus, a rarely diagnosed corneal disorder. Glaukos continues to successfully develop and advance a robust pipeline of novel, dropless platform technologies designed to meaningfully advance the standard of care and improve outcomes for patients suffering from chronic eye diseases.<\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20250625995676r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\" \/><span class=\"bwct31415\" \/><\/p>\n<p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20250625995676\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20250625995676\/en\/<\/a><\/span><\/p>\n<p>\nInvestor Contact:<br \/>\n<br \/>Chris Lewis<br \/>\n<br \/>Vice President, Investor Relations &amp; Corporate Affairs<br \/>\n<br \/>(949) 481-0510<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:clewis@glaukos.com\">clewis@glaukos.com<\/a><\/p>\n<p>\nMedia Contact:<br \/>\n<br \/>Andria Arena<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:aarena@jpa.com\">aarena@jpa.com<\/a><\/p>\n<p><b>KEYWORDS:<\/b> United States North America California<\/p>\n<p><b>INDUSTRY KEYWORDS:<\/b> Medical Devices Health Health Technology Pharmaceutical Optical Biotechnology<\/p>\n<p><b>MEDIA:<\/b><\/p>\n<table cellpadding=\"3\" cellspacing=\"3\">\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Logo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20250625995676\/en\/1258312\/3\/GlaukosRLogo_color_no_tagline.jpg\" alt=\"Logo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"<p>Glaukos to Celebrate 10th Anniversary of IPO Listing with NYSE Closing Bell ALISO VIEJO, Calif.&#8211;(BUSINESS WIRE)&#8211; Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced it will celebrate the 10th anniversary of its Initial Public Offering (IPO) listing on the New York Stock Exchange (NYSE) by ringing The Closing Bell at 4:00 p.m. ET today, Wednesday, June 25, 2025. &#8220;Ringing the NYSE closing bell today is a proud and humbling moment for our company, commemorating ten years since our IPO and celebrating the tremendous progress we\u2019ve made in advancing our mission to transform vision therapies for the benefit of patients suffering from &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/glaukos-to-celebrate-10th-anniversary-of-ipo-listing-with-nyse-closing-bell\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Glaukos to Celebrate 10th Anniversary of IPO Listing with NYSE Closing Bell&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-863507","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Glaukos to Celebrate 10th Anniversary of IPO Listing with NYSE Closing Bell - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/glaukos-to-celebrate-10th-anniversary-of-ipo-listing-with-nyse-closing-bell\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Glaukos to Celebrate 10th Anniversary of IPO Listing with NYSE Closing Bell - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Glaukos to Celebrate 10th Anniversary of IPO Listing with NYSE Closing Bell ALISO VIEJO, Calif.&#8211;(BUSINESS WIRE)&#8211; Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced it will celebrate the 10th anniversary of its Initial Public Offering (IPO) listing on the New York Stock Exchange (NYSE) by ringing The Closing Bell at 4:00 p.m. ET today, Wednesday, June 25, 2025. &#8220;Ringing the NYSE closing bell today is a proud and humbling moment for our company, commemorating ten years since our IPO and celebrating the tremendous progress we\u2019ve made in advancing our mission to transform vision therapies for the benefit of patients suffering from &hellip; Continue reading &quot;Glaukos to Celebrate 10th Anniversary of IPO Listing with NYSE Closing Bell&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/glaukos-to-celebrate-10th-anniversary-of-ipo-listing-with-nyse-closing-bell\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-06-25T11:04:10+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20250625995676r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/glaukos-to-celebrate-10th-anniversary-of-ipo-listing-with-nyse-closing-bell\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/glaukos-to-celebrate-10th-anniversary-of-ipo-listing-with-nyse-closing-bell\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Glaukos to Celebrate 10th Anniversary of IPO Listing with NYSE Closing Bell\",\"datePublished\":\"2025-06-25T11:04:10+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/glaukos-to-celebrate-10th-anniversary-of-ipo-listing-with-nyse-closing-bell\\\/\"},\"wordCount\":470,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/glaukos-to-celebrate-10th-anniversary-of-ipo-listing-with-nyse-closing-bell\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20250625995676r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/glaukos-to-celebrate-10th-anniversary-of-ipo-listing-with-nyse-closing-bell\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/glaukos-to-celebrate-10th-anniversary-of-ipo-listing-with-nyse-closing-bell\\\/\",\"name\":\"Glaukos to Celebrate 10th Anniversary of IPO Listing with NYSE Closing Bell - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/glaukos-to-celebrate-10th-anniversary-of-ipo-listing-with-nyse-closing-bell\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/glaukos-to-celebrate-10th-anniversary-of-ipo-listing-with-nyse-closing-bell\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20250625995676r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"datePublished\":\"2025-06-25T11:04:10+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/glaukos-to-celebrate-10th-anniversary-of-ipo-listing-with-nyse-closing-bell\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/glaukos-to-celebrate-10th-anniversary-of-ipo-listing-with-nyse-closing-bell\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/glaukos-to-celebrate-10th-anniversary-of-ipo-listing-with-nyse-closing-bell\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20250625995676r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20250625995676r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/glaukos-to-celebrate-10th-anniversary-of-ipo-listing-with-nyse-closing-bell\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Glaukos to Celebrate 10th Anniversary of IPO Listing with NYSE Closing Bell\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Glaukos to Celebrate 10th Anniversary of IPO Listing with NYSE Closing Bell - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/glaukos-to-celebrate-10th-anniversary-of-ipo-listing-with-nyse-closing-bell\/","og_locale":"en_US","og_type":"article","og_title":"Glaukos to Celebrate 10th Anniversary of IPO Listing with NYSE Closing Bell - Market Newsdesk","og_description":"Glaukos to Celebrate 10th Anniversary of IPO Listing with NYSE Closing Bell ALISO VIEJO, Calif.&#8211;(BUSINESS WIRE)&#8211; Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced it will celebrate the 10th anniversary of its Initial Public Offering (IPO) listing on the New York Stock Exchange (NYSE) by ringing The Closing Bell at 4:00 p.m. ET today, Wednesday, June 25, 2025. &#8220;Ringing the NYSE closing bell today is a proud and humbling moment for our company, commemorating ten years since our IPO and celebrating the tremendous progress we\u2019ve made in advancing our mission to transform vision therapies for the benefit of patients suffering from &hellip; Continue reading \"Glaukos to Celebrate 10th Anniversary of IPO Listing with NYSE Closing Bell\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/glaukos-to-celebrate-10th-anniversary-of-ipo-listing-with-nyse-closing-bell\/","og_site_name":"Market Newsdesk","article_published_time":"2025-06-25T11:04:10+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20250625995676r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/glaukos-to-celebrate-10th-anniversary-of-ipo-listing-with-nyse-closing-bell\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/glaukos-to-celebrate-10th-anniversary-of-ipo-listing-with-nyse-closing-bell\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Glaukos to Celebrate 10th Anniversary of IPO Listing with NYSE Closing Bell","datePublished":"2025-06-25T11:04:10+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/glaukos-to-celebrate-10th-anniversary-of-ipo-listing-with-nyse-closing-bell\/"},"wordCount":470,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/glaukos-to-celebrate-10th-anniversary-of-ipo-listing-with-nyse-closing-bell\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20250625995676r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/glaukos-to-celebrate-10th-anniversary-of-ipo-listing-with-nyse-closing-bell\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/glaukos-to-celebrate-10th-anniversary-of-ipo-listing-with-nyse-closing-bell\/","name":"Glaukos to Celebrate 10th Anniversary of IPO Listing with NYSE Closing Bell - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/glaukos-to-celebrate-10th-anniversary-of-ipo-listing-with-nyse-closing-bell\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/glaukos-to-celebrate-10th-anniversary-of-ipo-listing-with-nyse-closing-bell\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20250625995676r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","datePublished":"2025-06-25T11:04:10+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/glaukos-to-celebrate-10th-anniversary-of-ipo-listing-with-nyse-closing-bell\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/glaukos-to-celebrate-10th-anniversary-of-ipo-listing-with-nyse-closing-bell\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/glaukos-to-celebrate-10th-anniversary-of-ipo-listing-with-nyse-closing-bell\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20250625995676r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20250625995676r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/glaukos-to-celebrate-10th-anniversary-of-ipo-listing-with-nyse-closing-bell\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Glaukos to Celebrate 10th Anniversary of IPO Listing with NYSE Closing Bell"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/863507","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=863507"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/863507\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=863507"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=863507"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=863507"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}